HIV Podcast for Heterosexual African American Adults for HIV, Prevention

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Jacob's Home for Men, Houston, TX
HIV, Prevention+1 More
HIV Podcast for Heterosexual African American Adults - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Given the continued impact of HIV among African Americans, there is still an urgent need to expand prevention efforts and HIV testing in African American communities. Heterosexual individuals may acquire and spread infection directly through heterosexual contact, bi-sexual sexual contact, and/or indirectly through homosexual sexual contact. Evidence-based interventions (EBIs) have been shown to increase consistent condom use, decrease sexual partners, and increase HIV testing; however, traditionally-implemented EBIs may not be accessible to communities given the resources and expertise needed to implement them. This project seeks to: 1) assess feasibility for the development of two theory- based, video podcast-delivered, HIV prevention interventions for self-identified heterosexual African American males and females; and 2) evaluate their feasibility & effectiveness (pilot). The investigators will develop the two (male and female) video podcasts that maintain the theoretical integrity of two established Centers for Disease Control evidence-based behavioral HIV prevention interventions. The assessment phase will consist of leveraging African American community stakeholders and experts in the development of the podcast content. The effectiveness phase will consist of broadcasting the podcasts for participants and evaluating psychosocial factors related to HIV prevention at 1 and 3 month follow-ups. This intervention is the first of its kind and has the potential to increase HIV protective behaviors in this hard-to-reach and medically underserved population. The resulting interventions are expected to be easily disseminated throughout the African American communities, with the potential to reduce HIV- related disparities within this population. This study will impact and advance the field by demonstrating feasibility and effectiveness for a novel mode of intervention engagement within HIV prevention science, serve as valuable preliminary data for a larger R01 trial, and foster HIV prevention awareness within the African American community.

Eligible Conditions

  • HIV, Prevention

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for HIV, Prevention

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: To be measured immediately before film viewing (baseline) and 1 month after film viewing

Month 3
HIV test behavior: Have you obtained a HIV test (-you will not be required to disclose the results of this test)? (single item)
HIV test intentions: Do you intend to obtain a HIV test? (single item)
Month 1
Change from baseline socio-cultural perceptions of HIV prevention at 3 months followup

Trial Safety

Safety Progress

1 of 3

Other trials for HIV, Prevention

Trial Design

1 Treatment Group

African American Heterosexuals
1 of 1
Experimental Treatment

128 Total Participants · 1 Treatment Group

Primary Treatment: HIV Podcast for Heterosexual African American Adults · No Placebo Group · N/A

African American Heterosexuals
Behavioral
Experimental Group · 1 Intervention: HIV Podcast for Heterosexual African American Adults · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: to be measured immediately before film viewing (baseline) and 1 month after film viewing
Closest Location: Jacob's Home for Men · Houston, TX
Photo of Houston 1Photo of Houston 2Photo of Houston 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching HIV, Prevention
0 CompletedClinical Trials

Who is running the clinical trial?

University of HoustonLead Sponsor
122 Previous Clinical Trials
39,025 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You must be at least 18 years old.
You are fluent in English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.